Dr. Barbara E. Corkey talks about how many new plastics haven’t really been tested for their potential effects on the human body, including causing obesity and/or diabetes. She also mentions other substances including fire retardants and pesticides that are likewise not fully tested, and advocates for more testing of these …

Dr. Barbara E. Corkey talks about a few of the 5,000 substances that haven’t really been studied for their effects of obesity and urges more collaboration between researchers in academia and the food and packaging industries. More videos with Dr. Corkey: Introduction: The Unknown Causes of Diabetes and Obesity What …

Dr. Barbara E. Corkey talks about the huge amount of misinformation on the internet regarding substances that may or not cause diabetes. She points out that most of what we know is actually based on correlation rather than solid evidence and cites the example of the U.S. government’s decision to …

Dr. Barbara E. Corkey, talks about how the current dogma on how our obese patients should lose weight to combat diabetes is simply not working. She notes that we seem to be focusing too much on the wrong things – sending patients home with the advice to lose weight – …

In this week’s Homerun Slides from Dr. Stanley Schwartz, we look into exactly what a more aggressive therapy towards treating diabetes might look like with a review of dual and triple therapy approaches as well as which medications can be used and when. We also examine the cardiovascular impact of these …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP There is a steep age-related increase in the prevalence of diabetes and impaired glucose tolerance which applies equally to both sexes. Overall, diabetes prevalence is higher in men, but there are more women with diabetes. In devel­oping countries, most people with diabetes …

A recent published study evaluated 98 youths aged 10 to 18 years with BMI ≥85th percentile and not on medication for glucose management to determine if HbA1c or the oral glucose tolerance test is a better predictor of free-living glycemia as measured by continuous glucose monitoring (CGM). A blinded CGM …

The Endocrine Society has released a clinical practice guideline on the pharmacological management of obesity that includes recommendations on strategies for prescribing weight loss drugs.

An ultra-thin, flexible sensor that sticks to the skin like a temporary tattoo can detect a person’s blood glucose levels… “The sensor represents the first example of an easy-to-wear flexible tattoo-based epidermal diagnostic device combining reverse iontophoretic extraction of interstitial glucose and an enzyme-based amperometric biosensor,” the researchers wrote. In …

The FDA has approved the Maestro Rechargeable System for treatment of obesity… The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight …